Suppr超能文献

肺癌筛查不符合美国预防服务工作组的建议。

Lung Cancer Screening Inconsistent With U.S. Preventive Services Task Force Recommendations.

机构信息

Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.

出版信息

Am J Prev Med. 2019 Jan;56(1):66-73. doi: 10.1016/j.amepre.2018.07.030. Epub 2018 Nov 19.

Abstract

INTRODUCTION

Prior studies suggest overuse of nonrecommended lung cancer screening tests in U.S. community practice and underuse of recommended tests.

METHODS

Data from the 2010 and 2015 National Health Interview Surveys was analyzed from 2016 to 2018. Prevalence, populations, and number of chest computed tomography (CT) and chest x-ray tests were estimated for people who did and did not meet U.S. Preventive Services Task Force (USPSTF) criteria for lung cancer screening, among people aged ≥40 years without lung cancer.

RESULTS

In 2015, among those who met USPSTF criteria, 4.4% (95% CI=3.0%, 6.6%), or 360,000 (95% CI=240,000, 535,000) people reported lung cancer screening with a chest CT; and 8.5% (95% CI=6.5%, 11.1%), or 689,000 (95% CI=526,000, 898,000) people reported a chest x ray. Among those who did not meet USPSTF criteria, 2.3% (95% CI=2.0%, 2.6%), or 3,259,000 (95% CI=2,850,000, 3,724,000) people reported a chest x ray; and 1.3% (95% CI=1.1%, 1.5%), or 1,806,000 (95% CI=1,495,000, 2,173,000) people reported a chest CT. The estimated population meeting USPSTF criteria for lung cancer screening in 2015 was 8,098,000 (95% CI=7,533,000, 8,702,000), which was smaller than the 9,620,000 people (95% CI=8,960,000, 10,325,000) in 2010.

CONCLUSIONS

The number of adults inappropriately screened for lung cancer greatly exceeds the number screened according to USPSTF recommendations, the prevalence of appropriate lung cancer screening is low, and the population meeting USPSTF criteria is shrinking. To realize the potential benefits of screening, better processes to appropriately triage eligible individuals to screening, plus screening with a USPSTF-recommended test, would be beneficial.

摘要

简介

先前的研究表明,美国社区实践中过度使用了非推荐的肺癌筛查检测,而对推荐的检测则使用不足。

方法

对 2016 年至 2018 年来自 2010 年和 2015 年全国健康访谈调查的数据进行了分析。在没有肺癌的 40 岁及以上人群中,根据美国预防服务工作组(USPSTF)的肺癌筛查标准,对符合和不符合标准的人群进行了胸部计算机断层扫描(CT)和胸部 X 线检查的流行率、人群和数量估计。

结果

2015 年,在符合 USPSTF 标准的人群中,有 4.4%(95%CI=3.0%,6.6%),即 36 万人(95%CI=24 万,53.5 万)进行了胸部 CT 肺癌筛查;有 8.5%(95%CI=6.5%,11.1%),即 68.9 万人(95%CI=52.6 万,89.8 万)进行了胸部 X 线检查。在不符合 USPSTF 标准的人群中,有 2.3%(95%CI=2.0%,2.6%),即 325.9 万人(95%CI=285 万,372.4 万)进行了胸部 X 线检查;有 1.3%(95%CI=1.1%,1.5%),即 180.6 万人(95%CI=149.5 万,217.3 万)进行了胸部 CT 检查。2015 年符合 USPSTF 肺癌筛查标准的估计人口为 809.8 万人(95%CI=753.3 万,870.2 万),小于 2010 年的 962 万人(95%CI=896 万,1032.5 万)。

结论

不适当进行肺癌筛查的成年人数量大大超过了根据 USPSTF 建议进行筛查的人数,适当肺癌筛查的流行率较低,符合 USPSTF 标准的人群正在缩小。为了实现筛查的潜在益处,更好的方法是适当将符合条件的个人分诊到筛查中,并使用 USPSTF 推荐的检测方法进行筛查。

相似文献

1
Lung Cancer Screening Inconsistent With U.S. Preventive Services Task Force Recommendations.
Am J Prev Med. 2019 Jan;56(1):66-73. doi: 10.1016/j.amepre.2018.07.030. Epub 2018 Nov 19.
3
Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey.
Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1049-59. doi: 10.1158/1055-9965.EPI-12-0343. Epub 2012 May 9.
6
National Survey of Lung Cancer Screening Eligibility in United States Veterans.
Am J Prev Med. 2025 May;68(5):886-895. doi: 10.1016/j.amepre.2025.01.015. Epub 2025 Jan 27.
8
Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.
PLoS Med. 2014 Dec 2;11(12):e1001764. doi: 10.1371/journal.pmed.1001764. eCollection 2014 Dec.

引用本文的文献

1
A Geospatial Analysis of the Lung Cancer Burden in Philadelphia, Using Pennsylvania Cancer Registry Data from 2008-2017.
Int J Environ Res Public Health. 2025 Mar 20;22(3):455. doi: 10.3390/ijerph22030455.
2
Lung Cancer Screening Rates in the United States: Contribution of the 2020 NHIS Estimates to National and State-Level Trends.
Am J Prev Med. 2025 Jul;69(1):107626. doi: 10.1016/j.amepre.2025.03.006. Epub 2025 Mar 27.
3
Optimal Pathways to Lung Cancer Screening in Primary Care Settings: A Scoping Review.
Curr Oncol. 2024 Dec 26;32(1):8. doi: 10.3390/curroncol32010008.
8
Deep learning to estimate lung disease mortality from chest radiographs.
Nat Commun. 2023 May 16;14(1):2797. doi: 10.1038/s41467-023-37758-5.
10
A narrative review of lung cancer screening in underserved populations.
Curr Chall Thorac Surg. 2023;5. doi: 10.21037/ccts-20-173. Epub 2023 Feb 25.

本文引用的文献

1
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
Chest. 2018 Apr;153(4):954-985. doi: 10.1016/j.chest.2018.01.016. Epub 2018 Feb 17.
3
Underuse of Chest Radiography Versus Computed Tomography for Lung Cancer Screening.
Am J Public Health. 2017 Aug;107(8):1248-1250. doi: 10.2105/AJPH.2017.303919.
4
Monitoring Lung Cancer Screening Use and Outcomes at Four Cancer Research Network Sites.
Ann Am Thorac Soc. 2017 Dec;14(12):1827-1835. doi: 10.1513/AnnalsATS.201703-237OC.
5
Cancer Screening Test Use - United States, 2015.
MMWR Morb Mortal Wkly Rep. 2017 Mar 3;66(8):201-206. doi: 10.15585/mmwr.mm6608a1.
6
Lung Cancer Screening With Low-Dose Computed Tomography in the United States-2010 to 2015.
JAMA Oncol. 2017 Sep 1;3(9):1278-1281. doi: 10.1001/jamaoncol.2016.6416.
7
Implementation of Lung Cancer Screening in the Veterans Health Administration.
JAMA Intern Med. 2017 Mar 1;177(3):399-406. doi: 10.1001/jamainternmed.2016.9022.
9
Current cigarette smoking among adults - United States, 2005-2014.
MMWR Morb Mortal Wkly Rep. 2015 Nov 13;64(44):1233-40. doi: 10.15585/mmwr.mm6444a2.
10
Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center.
Rev Recent Clin Trials. 2015;10(3):194-9. doi: 10.2174/1574887110666150731145929.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验